Recursion Pharmaceuticals bounced back by 8.72 percent on Tuesday to close at $5.36 apiece following news that it acquired a ...

Shares in biotech company Recursion Pharmaceuticals ( RXRX 12.07%) surged by more than 12% by 11 a.m. ET today. The move is ...

Rallybio has swerved away from its Recursion Pharmaceuticals pact, accepting $7.5 million upfront for its share of a preclinical program to extend its cash runway to mid-2027.

Rallybio has agreed to sell its interest in a drug-development plan seeking to treat a rare genetic bone disease to its joint-venture partner Recursion Pharmaceuticals for up to $25 million.

Mobile robots need to explore novel environments to build useful maps for later navigation and motion planning. Sensor-based Random Tree, (SRT), technique had been used for exploration but it is ...

Car driving safety, comfort, energy economy and battery life extension are important factors for electric vehicles. To optimize these factors, this paper proposes an economic adaptive cruise control ...